Ensayo clínico

Cephea Early Feasibility Study

NCT: NCT05061004 · RECRUITING

ID NCTNCT05061004

EstadoRECRUITING

Fecha de inicio2022-04-28

Finalización2031-03-01

SponsorAbbott Medical Devices (INDUSTRY)

First posted2021-09-29

Last updated2026-09-11

Resumen breve

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

Fuente oficial

Ver en ClinicalTrials.gov →

Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.